Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 8Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 4Nasopharyngeal Carcinoma 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Neoplasms 2Neoplasm Metastasis 2Meningioma 2Liver Neoplasms 2HER2-positive Breast Cancer 2Glioma 2Glioblastoma 2Chordoma 2Carcinoma, Hepatocellular 2Carcinoma, Adenoid Cystic 2Brain Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Small Cell Lung Carcinoma 1Sinonasal undifferentiated carcinoma 1Resectable Lung Non-Small Cell Carcinoma 1Radiation Injuries 1Pituitary Neoplasms 1Oligodendroglioma 1Neurilemmoma 1Nerve Sheath Neoplasms 1

Interventions

Specimen Handling 2nedaplatin 1X-Rays 1Relaxation Therapy 1Protons 1Proton Therapy 1Platinum Compounds 1Physical Therapy Modalities 1Pemetrexed 1Paclitaxel 1Docetaxel 1Cisplatin 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Resectable Lung Non-Small Cell Carcinoma × Protons × Clear all
NCT06008730 2025-11-10

Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer

Emory University

Phase 2 Recruiting
20 enrolled

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡